Systemic anti-tumour immunity results from T cell priming in tumour-draining lymph nodes (TDLNs)1, 2, 3–4. Although the suppression of T cells in tumours is well characterized5, 6, 7–8, whether this occurs in TDLNs—and if so, through which mechanisms—remains poorly understood. Here, using imaging mass cytometry of TDLN...
A. van Krimpen, Julie Y. Huang, Mike Eterman et al.· Nature· 0 citations
It is suggested that in diseases caused by insufficient TNFAIP3/A20 activity, autoantibodies may reflect a downstream consequence of disease rather than a causative driver, suggesting autoinflammatory rather than autoimmune pathology.
Karel F. A. Van Damme, Pieter Hertens, D. Sichien et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.